In CRISPR-Cas13-transfected bladder cancer T24 and 5637 cell lines, GACAT3 promotes cell proliferation, suppresses apoptosis, and enhances cell migration by downregulating p21, BAX, and E-Cadherin protein levels, respectively. Here, GACAT3 is linked to urinary bladder cancer.